CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 52 enrolled
Drug / intervention
d-cycloserine +1 moredrug
Likely dose
d-cycloserine 50 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01526538
NCT01526538Phase 2Completed
CompareCT.gov

Improving Learning-based Treatment of Cocaine Dependence With Medication

Johns Hopkins University·interventional·Posted Feb 6, 2012·Updated Feb 15, 2017

In Brief

A Phase 2 clinical trial evaluating d-cycloserine and sugar pill for COCAINE-RELATED DISORDERS. Completed, enrolled 52 participants across 1 site.

Detailed Summary

This study will test the efficacy of d-cycloserine in enhancing response to learning-based treatment for cocaine dependence, specifically contingency management.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCOCAINE-RELATED DISORDERS
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedFeb 6, 2012
Enrollment StartSep 1, 2011
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 14.4 years ago

Interventions

d-cycloserinedrug

50 mg d-cycloserine

sugar pilldrug

placebo